ArticleCancers2025

Split-Dose Cisplatin Use, Eligibility Criteria, and Drivers for Treatment Choice in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: Results of a Large International Physician Survey.

Richard O'Dwyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.